Combinational Therapy in Triple Negative Breast Cancer

A comprehensive scientific examination of Triple-Negative Breast Cancer (TNBC), a particularly aggressive disease characterized by the lack of traditional hormonal receptors. The material details molecular classification systems used to categorize the illness into distinct subgroups, which helps clinicians identify specific targets for more effective therapy. Extensive focus is placed on innovative diagnostic tools, including blood-based liquid biopsies, nanobiosensors, and advanced imaging techniques that detect tumor-derived markers like ctDNA and miRNAs. The authors also explore the tumor microenvironment and the role of the immune system, highlighting how various cells and signaling pathways contribute to cancer progression or suppression. Furthermore, the sources evaluate a wide range of treatment strategies, spanning from traditional chemotherapy and radiotherapy to modern targeted interventions like PARP and PI3K inhibitors. Ultimately, the text emphasizes the shift toward personalized medicine by utilizing genetic and epigenetic biomarkers to improve patient outcomes.Get the Book now from Amazon:https://www.amazon.com/Combinational-Therapy-Triple-Negative-Breast/dp/0323961363?&linkCode=ll1&tag=cvthunderx-20&linkId=a29ad28d13d9efc1d158fc7dab4a07a2&language=en_US&ref_=as_li_ss_tlYou can listen and download our episodes for free on more than 10 different platforms:https://linktr.ee/medicine_made_simpleProduced by:https://www.podcaistudio.com/